<?xml version="1.0" encoding="UTF-8"?>

<?xml-stylesheet type="text/xsl" href="/static/oaitohtml.xsl"?>

<!--
<?xml-stylesheet type="text/xsl" href="/oaitohtml.xsl"?>
-->

<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <responseDate>2026-10-12T04:01:17Z</responseDate>
    <request verb="GetRecord" metadataPrefix="oai_dc" identifier="10.57760/sciencedb.43707" >https://www.scidb.cn/oai</request>
<GetRecord>
    <record>
    <header >
    <identifier>10.57760/sciencedb.43707</identifier>
    <datestamp>2026-07-21T16:14:39Z</datestamp>
</header>
    <metadata>
        
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:date>2026-07-21</dc:date>
  <dc:title>dataset for Multivalent Nanoparticles Activate T-dependent antibody response via Antigen Presentation by both B Cells and Dendritic Cells</dc:title>
  <dc:identifier>doi:10.57760/sciencedb.43707</dc:identifier>
  <dc:language>en</dc:language>
  <dc:description>Multivalent nanoparticle vaccines elicit potent T cell-dependent (TD) antibody responses, yet how they initiate CD4+ T cell help remains unclear. Here, we show that antigen-specific B cells function as antigen-presenting cells (APCs) for CD4+ T cell priming across distinct nanoparticle platforms, including AP205 and ferritin. Using SARS-CoV-2 RBD and mpox virus A35 antigens, we demonstrate that B cells and dendritic cells (DCs) act redundantly to initiate early CD4+ T cell activation. In hosts lacking MHC class II expression on non-B cells, B cells alone were sufficient to drive naive CD4+ T cell proliferation. Moreover, B cell-mediated antigen presentation was required for inducing TD responses beyond the draining lymph nodes. These findings reveal a general mechanism by which multivalent nanoparticles engage B cells as APCs and highlight a potential strategy to enhance vaccine-induced immunity.</dc:description>
  <dc:subject>nanoparticle; antibody response; antigen presentation</dc:subject>
  <dc:creator>Hou Baidong</dc:creator>
  <dc:creator>Hua Zhaolin</dc:creator>
  <dc:rights>PUBLIC</dc:rights>
  <dc:rights>https://creativecommons.org/publicdomain/zero/1.0/</dc:rights>
  <dc:type>dataset</dc:type>
  <dc:publisher>Science Data Bank</dc:publisher>
</oai_dc:dc>

    </metadata>
</record>
</GetRecord>
</OAI-PMH>